Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25 (N.D.W.Va. May. 11, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25 (N.D.W.Va. May. 11, 2022)
+ More Snippets
Document
IPR2023-00724, No. 74 Other other - Patent Owners Sur Reply PUBLIC (P.T.A.B. Aug. 5, 2024)
Cite Document
IPR2023-00724, No. 74 Other other - Patent Owners Sur Reply PUBLIC (P.T.A.B. Aug. 5, 2024)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22 (N.D.W.Va. May. 6, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22 (N.D.W.Va. May. 6, 2022)
+ More Snippets
Document
IPR2024-00009, No. 15 Other other - Patent Owners Sur Reply (P.T.A.B. Mar. 6, 2024)
Cite Document
IPR2024-00009, No. 15 Other other - Patent Owners Sur Reply (P.T.A.B. Mar. 6, 2024)
+ More Snippets
Document
IPR2024-00631, No. 6 Notice Power of Attorney - Patent Owners Power of Attorney Designation of Lead and Back Up Counsel (P.T.A.B. Mar. 6, 2024)
Cite Document
IPR2024-00631, No. 6 Notice Power of Attorney - Patent Owners Power of Attorney Designation of Lead and Back Up Counsel (P.T.A.B. Mar. 6, 2024)
+ More Snippets
Document
IPR2024-00631, No. 7 Notice Mandatory Notice - Patent Owners Mandatory Notices (P.T.A.B. Mar. 6, 2024)
Cite Document
IPR2024-00631, No. 7 Notice Mandatory Notice - Patent Owners Mandatory Notices (P.T.A.B. Mar. 6, 2024)
+ More Snippets
Document
IPR2023-00724, No. 68 Notice Exhibit list - Patent Owners Updated Exhibit List (P.T.A.B. Jul. 25, 2024)
Cite Document
IPR2023-00724, No. 68 Notice Exhibit list - Patent Owners Updated Exhibit List (P.T.A.B. Jul. 25, 2024)
+ More Snippets
Document
IPR2024-00631, No. 2 Notice Power of Attorney - Notice Power of Attorney (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 2 Notice Power of Attorney - Notice Power of Attorney (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1 Petition as filed - Petition as filed (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1 Petition as filed - Petition as filed (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00009, No. 14 Pet Reply to PO Resp - Petitioners’ Reply To Patent Owner’s Preliminary Response (P.T.A.B. Feb. 21, 2024)
Cite Document
IPR2024-00009, No. 14 Pet Reply to PO Resp - Petitioners’ Reply To Patent Owner’s Preliminary Response (P.T.A.B. Feb. 21, 2024)
+ More Snippets
Document
IPR2023-00724, No. 66 Other other - Petitioners Request for Oral Argument (P.T.A.B. Jul. 12, 2024)
Cite Document
IPR2023-00724, No. 66 Other other - Petitioners Request for Oral Argument (P.T.A.B. Jul. 12, 2024)
+ More Snippets
Document
IPR2023-00724, No. 67 Other other - Patent Owners Request for Oral Hearing (P.T.A.B. Jul. 12, 2024)
Cite Document
IPR2023-00724, No. 67 Other other - Patent Owners Request for Oral Hearing (P.T.A.B. Jul. 12, 2024)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 20 (N.D.W.Va. Apr. 8, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 20 (N.D.W.Va. Apr. 8, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 13 (N.D.W.Va. Mar. 28, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 13 (N.D.W.Va. Mar. 28, 2022)
+ More Snippets
Document
IPR2023-00724, No. 65 Pet Reply to PO Resp - Redacted Petitioners Reply (P.T.A.B. Jun. 21, 2024)
Cite Document
IPR2023-00724, No. 65 Pet Reply to PO Resp - Redacted Petitioners Reply (P.T.A.B. Jun. 21, 2024)
+ More Snippets